• HeartSciences received a Nasdaq notice on Aug. 4, 2026 for failing the $2.5 million minimum stockholders’ equity rule.
• Stockholders’ equity was 226,060 in its Form 10-K for the fiscal year ended April 30, 2026.
• Nasdaq set a Sept. 18, 2026 deadline to submit a compliance plan; potential extension runs to Jan. 31, 2027.
• Shares and public warrants keep trading on Nasdaq for now; delisting risk rises if compliance is not restored.
• Management is weighing options, including the planned all-stock merger with Fortitude Mining, to support a return to compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-086773), on August 07, 2026, and is solely responsible for the information contained therein.